REG - MD Medical Group - MDMG OPENS FIRST LAB FOR COLLECTION OF ANALYZES

MD Medical InvestmentsAnnouncement

10/12/2021 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20211210:nRSJ2053Va&default-theme=true

RNS Number : 2053V  MD Medical Group Investments PLC  10 December 2021

 

MDMG OPENs FIRST LAB FOR COLLECTION OF ANALYZES

 

10 December 2021 - MD Medical Group Investments Plc ("MD Medical Group",
"MDMG" or the "Company" - LSE, MOEX: MDMG), a leading Russian private
healthcare provider, today announces the opening of its first lab for
collection of analyzes.

It will operate under the special "MD LAB" brand in the North-Eastern
Administrative District of Moscow.

The surface of the new lab is around 80 meters. It is fully equipped with
modern equipment that allows to provide patients with a wide range of
analyzes. All analyzes will be processed in the multifunctional laboratory
that was opened in the "Lapino-2" hospital and possesses huge diagnostic
resources.

It is expected that in the future several similar labs will be opened in
different districts of Moscow and the Moscow region. Thus, the Company will
continue to expand its presence in highly populated areas with steady consumer
demand.

Mark Kurtser, CEO of MD Medical Group, said:

"By opening our first stand-alone laboratory, the Company begins to operate a
new format of medical centers. These mini-laboratories will provide a new type
of service for our patients, facilitating access to the services of the
"Mother and Child" medical centers and contributing to the expansion of the
Company's client base".

Sergey Arabadzhyan, Medical Director for Innovative Technologies of MD Medical
Group, said:

 

"MD LAB" centers will increase patient loyalty, giving them the opportunity to
appreciate all the benefits of medical services provided by the "Mother and
Child" Group of companies. The initial regions for the new format will be
Moscow and the Moscow Region where transport accessibility plays a huge role".

 

 

 

 

 

This announcement contains inside information.

For further information please contact:
 Investors                                 Media
                                           EM

Tom Blackwell: +7 919 102 9064
 Dmitry Yakushkin

                                         Sergii Pershyn: +1 929 855 8188
 MD Medical Group Investments Plc

                                         MDMG@em-comms.com (mailto:MDMG@em-comms.com)
 тел.: +7 (495) 139-87-40, ext. 16329
 d.yakushkin@mcclinics.ru

About MD Medical Group

MD Medical Group is a leading provider in the highly attractive Russian
private healthcare service market. The company manages 43 modern healthcare
facilities, including 6 hospitals and 37 out-patient clinics in Moscow and the
Moscow Region, St. Petersburg, Ufa, Perm, Samara and the Samara Region,
Novosibirsk, Irkutsk, Yaroslavl, Ryazan, Kostroma, Novokuznetsk, Krasnoyarsk,
Omsk, Barnaul, Vladimir, Tyumen, Voronezh, Nizhny Novgorod, Volgograd, Tula,
Kazan, Vladivostok, Krasnodar and Rostov-on-Don.

The Company's shares have been listed on the London Stock Exchange (LSE ticker
"MDMG") in the form of Global Depositary Receipts (GDRs) since 12 October
2012.

Since 9 November 2020, the Company's GDRs are traded also on the Moscow
Exchange. Quotation is done in Russian Rubles.

Forward-Looking Statements:

This press release contains forward looking statements, which are based on the
Company's current expectations and assumptions and may involve known and
unknown risks and uncertainties that could cause actual results, performance
or events to differ materially from those expressed or implied in such
statements. The forward looking statements contained in this press release are
based on past trends or activities and should not be taken that such trends or
activities will continue in the future. It is believed that the expectations
reflected in these statements are reasonable, but they may be affected by a
number of variables which could cause actual results or trends to differ
materially, including, but not limited to: conditions in the market, market
position of the Company, earnings, financial position, cash flows, return on
capital and operating margins, anticipated investments and economic
conditions; the Company's ability to obtain capital/additional finance; a
reduction in demand by customers; an increase in competition; an unexpected
decline in revenue or profitability; legislative, fiscal and regulatory
developments, including, but not limited to, changes in environmental and
health and safety regulations; exchange rate fluctuations; retention of senior
management; the maintenance of labour relations; fluctuations in the cost of
input costs; and operating and financial restrictions as a result of financing
arrangements.

No statement in this press release is intended to constitute a profit
forecast, nor should any statements be interpreted to mean that earnings or
earnings per share will necessarily be greater or lesser than those for the
relevant preceding financial periods for the Company. Each forward looking
statement relates only as of the date of the particular statement.

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCFSEEEUEFSEDE